Heme oxygenase expression in human central nervous system disorders

Free Radical Biology and Medicine

Volumn 37, Issue 12, 2004, Pages 1995-2011

  Schipper, Hyman M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Aging; Alzheimer disease; Astrocyte; Cerebrovascular disease; Corpora amylacea; Free radicals; Heme oxygenase; Iron; Mitochondria; Multiple sclerosis; Neurodegeneration; Oxidative stress; Parkinson disease

Indexed keywords

HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2;

AGE DISTRIBUTION; AGING; ALZHEIMER DISEASE; ASTROCYTE; BRAIN INFARCTION; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; GENE INDUCTION; GLIA CELL; HUMAN; IMMUNOREACTIVITY; MACROGLIA; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SENILE PLAQUE; SEX ROLE; SUBSTANTIA NIGRA; UPREGULATION;

AGING; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HEME OXYGENASE (DECYCLIZING); HUMANS; IRON;

ANIMALIA; MAMMALIA;

EID: 8544257019     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.09.015     Document Type: Review

References (142)

1. H.M. Schipper Redox neurology: visions of an emerging subspecialty Ann. N. Y. Acad. Sci. 1012 2004 342 355
2. S.W. Ryter, and R.M. Tyrrell The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties Free Radic. Biol. Med. 28 2000 289 309
3. J.F. Ewing, and M.D. Maines Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript Brain Res. 672 1995 29 41
4. G. Scapagnini, V. D'Agata, V. Calabrese, A. Pascale, C. Colombrita, D. Alkon, and S. Cavallaro Gene expression profiles of heme oxygenase isoforms in the rat brain Brain Res. 954 2002 51 59
5. A. Verma, D.J. Hirsch, C.E. Glatt, G.V. Ronnett, and S.H. Snyder Carbon monoxide: a putative neural messenger Science 259 1993 381 384
6. V. Calabrese, G. Scapagnini, A. Ravagna, R.G. Fariello, A.M. Giuffrida Stella, and N.G. Abraham Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance J. Neurosci. Res. 68 2002 65 75
7. D.E. Baranano, and S.H. Snyder Neural roles for heme oxygenase: contrasts to nitric oxide synthase Proc. Natl. Acad. Sci. USA 98 2001 10996 11002
8. P.A. Dennery Regulation and role of heme oxygenase in oxidative injury Curr. Top. Cell Regul. 36 2000 181 199
9. H.M. Schipper Heme oxygenase-1: role in brain aging and neurodegeneration Exp. Gerontol. 35 2000 821 830
10. Y. Matsuoka, Y. Kitamura, M. Okazaki, J. Kakimura, I. Tooyama, H. Kimura, and T. Taniguchi Kainic acid induction of heme oxygenase in vivo and in vitro Neuroscience 85 1998 1223 1233
11. R. Stocker, Y. Yamamoto, A.F. McDonagh, A.N. Glazer, and B.N. Ames Bilirubin is an antioxidant of possible physiological importance Science 235 1987 1043 1046
12. T. Nakagami, K. Toyomura, T. Kinoshita, and S. Morisawa A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin Biochim. Biophys. Acta 1158 1993 189 193
13. S.F. Llesuy, and M.L. Tomaro Heme oxygenase and oxidative stress: evidence of involvement of bilirubin as physiological protector against oxidative damage Biochim. Biophys. Acta 1223 1994 9 14
14. S. Dore, M. Takahashi, C.D. Ferris, R. Zakhary, L.D. Hester, D. Guastella, and S.H. Snyder Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury Proc. Natl. Acad. Sci. USA 96 1999 2445 2450
15. D. Willis, A.R. Moore, R. Frederick, and D.A. Willoughby Heme oxygenase: a novel target for the modulation of the inflammatory response Nat. Med. 2 1996 87 90
16. A. Tosaki, and D.K. Das The role of heme oxygenase signaling in various disorders Mol. Cell. Biochem. 232 2002 149 157
17. J. Zhang, and C.A. Piantadosi Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain J. Clin. Invest. 90 1992 1193 1199
18. D. Frankel, K. Mehindate, and H.M. Schipper Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia J. Cell. Physiol. 185 2000 80 86
19. R. Galbraith Heme oxygenase: who needs it? Proc. Soc. Exp. Biol. Med. 222 1999 299 305
20. D.M. Suttner, and P.A. Dennery Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron FASEB J. 13 1999 1800 1809
21. B.E. Dwyer, R.N. Nishimura, and S.Y. Lu Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody: response to oxidative stress Brain Res. Mol. Brain Res. 30 1995 37 47
22. F. Manganaro, V.S. Chopra, M.B. Mydlarski, G. Bernatchez, and H.M. Schipper Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain Free Radic. Biol. Med. 19 1995 823 835
23. M.D. Maines, B. Polevoda, T. Coban, K. Johnson, S. Stoliar, T.J. Huang, N. Panahian, D.A. Cory-Slechta, and W.K. McCoubrey Jr. Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal NADPH diaphorase staining J. Neurochem. 70 1998 2057 2069
24. N. Panahian, M. Yoshiura, and M.D. Maines Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice J. Neurochem. 72 1999 1187 1203
25. K. Fukuda, J.D. Richmon, M. Sato, F.R. Sharp, S.S. Panter, and L.J. Noble Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury Brain Res. 736 1996 68 75
26. K. Chen, K. Gunter, and M.D. Maines Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death J. Neurochem. 75 2000 304 313
27. W.D. Le, W.J. Xie, and S.H. Appel Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury J. Neurosci. Res. 56 1999 652 658
28. A. Takeda, G. Perry, N.G. Abraham, B.E. Dwyer, R.K. Kutty, J.T. Laitinen, R.B. Petersen, and M.A. Smith Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau J. Biol. Chem. 275 2000 5395 5399
29. H. Suzuki, K. Kanamaru, H. Tsunoda, H. Inada, M. Kuroki, H. Sun, S. Waga, and T. Tanaka Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats J. Clin. Invest. 104 1999 59 66
30. T. Tanaka, Y. Nishimura, H. Tsunoda, and M. Naka Pharmacogenomics and therapeutic target validation in cerebral vasospasm J. Cardiovasc. Pharmacol. 36 Suppl. 2 2000 S1 S4
31. P. Matz, C. Turner, P.R. Weinstein, S.M. Massa, S.S. Panter, and F.R. Sharp Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage Brain Res. 713 1996 211 222
32. H. Suzuki, M. Muramatsu, T. Kojima, and W. Taki Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage Stroke 34 2003 2796 2800
33. C. Kadoya, E.F. Domino, G.Y. Yang, J.D. Stern, and A.L. Betz Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats Stroke 26 1995 1035 1038
34. A. Koeppen, A. Dickson, and J. Smith Heme oxygenase in brain hemorrhage: the benefit of tin-mesoporphyrin J. Neuropathol. Exp. Neurol. 63 2004 587 597
35. K.R. Wagner, Y. Hua, G.M. de Courten-Myers, J.P. Broderick, R.N. Nishimura, S.Y. Lu, and B.E. Dwyer Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies Cell. Mol. Biol. (Noisy-le-grand) 46 2000 597 608
36. F.P. Huang, G. Xi, R.F. Keep, Y. Hua, A. Nemoianu, and J.T. Hoff Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products J. Neurosurg. 96 2002 287 293
37. A.H. Koeppen, and A.C. Dickson Tin-protoporphyrin prevents experimental superficial siderosis in rabbits J. Neuropathol. Exp. Neurol. 61 2002 689 701
38. K.L. Panizzon, B.E. Dwyer, R.N. Nishimura, and R.A. Wallis Neuroprotection against CA1 injury with metalloporphyrins Neuroreport 7 1996 662 666
39. B. Rogers, V. Yakopson, Z.P. Teng, Y. Guo, and R.F. Regan Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity Free Radic. Biol. Med. 35 2003 872 881
40. H.M. Schipper Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress S. LeVine J.R. Connor H.M. Schipper Redox-active metals in neurological disorders 2004 N.Y. Acad. Sci. New York 84 93
41. H.M. Schipper Glial iron sequestration and neurodegeneration H.M. Schipper Astrocytes in brain aging and neurodegeneration 1998 R.G. Landes Austin (TX) 235 251
42. H.M. Schipper Astrocytes, brain aging, and neurodegeneration Neurobiol. Aging 17 1996 467 480
43. H. Schipper Brain iron deposition and the free radical-mitochondrial theory of ageing Ageing Res. Rev. 3 2004 265 301
44. X. Wang, F. Manganaro, and H.M. Schipper A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system J. Neurochem. 64 1995 1868 1877
45. H.M. Schipper Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases Neurotoxicol. Res. 1 1999 57 70
46. H.M. Schipper, L. Bernier, K. Mehindate, and D. Frankel Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore J. Neurochem. 72 1999 1802 1811
47. D. Ham, and H.M. Schipper Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides Cell. Mol. Biol. (Noisy-le-grand) 46 2000 587 596
48. K. Mehindate, D.J. Sahlas, D. Frankel, Y. Mawal, A. Liberman, J. Corcos, S. Dion, and H.M. Schipper Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis J. Neurochem. 77 2001 1386 1395
49. Y. Lavrovsky, G.S. Drummond, and N.G. Abraham Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements Biochem. Biophys. Res. Commun. 218 1996 759 765
50. W. Song, H. Su, S. Song, H. Paudel, and H. Schipper HO-1 over-expression promotes oxidative mitochondrial damage in rat astroglia 2004 Federation of American Societies for Experimental Biology Washington (DC)
51. V. Petronilli, C. Cola, S. Massari, R. Colonna, and P. Bernardi Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria J. Biol. Chem. 268 1993 21939 21945
52. K.M. Broekemeier, and D.R. Pfeiffer Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases Biochemistry 34 1995 16440 16449
53. W. Hirose, K. Ikematsu, and R. Tsuda Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain Leg. Med. (Tokyo) 5 2003 S360 S366 Suppl.
54. H.M. Schipper, S. Cissé, and E.G. Stopa Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain Ann. Neurol. 37 1995 758 768
55. S.G. Anthony, H.M. Schipper, R. Tavares, V. Hovanesian, S.C. Cortez, E.G. Stopa, and C.E. Johanson Stress protein expression in the Alzheimer-diseased choroid plexus J. Alzheimers Dis. 5 2003 171 177
56. H.M. Schipper, A. Liberman, and E.G. Stopa Neural heme oxygenase-1 expression in idiopathic Parkinson's disease Exp. Neurol. 150 1998 60 68
57. A.H. Stokes, T.G. Hastings, and K.E. Vrana Cytotoxic and genotoxic potential of dopamine J. Neurosci. Res. 55 1999 659 665
58. D.H.A. Mann Vulnerability of specific neurons to aging D.B. Calne Neurodegenerative diseases 1994 Saunders Philadelphia 15 31
59. G. Perry, R.J. Castellani, M.A. Smith, P.L. Harris, Z. Kubat, K. Ghanbari, P.K. Jones, G. Cordone, M. Tabaton, B. Wolozin, and H. Ghanbari Oxidative damage in the olfactory system in Alzheimer's disease Acta Neuropathol. (Berl.) 106 2003 552 556
60. M. Mydlarski, J. Deschenes, and H. Schipper Expression of heme oxygenase-1 in the human eye 2003 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Ft. Lauderdale (FL) E-Abstract 649
61. F.E. Samson, and S.R. Nelson The aging brain, metals and oxygen free radicals Cell. Mol. Biol. (Noisy-le-grand) 46 2000 699 707
62. A.W. Linnane, C. Zhang, A. Baumer, and P. Nagley Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention Mutat. Res. 275 1992 195 208
63. H.M. Schipper, and S. Cissé Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain Glia 14 1995 55 64
64. J.B. Cavanagh Corpora-amylacea and the family of polyglucosan diseases Brain Res. Brain Res. Rev. 29 1999 265 295
65. D.J. Sahlas, A. Liberman, and H.M. Schipper Role of heme oxygenase-1 in the biogenesis of corpora amylacea Biogerontology 3 2002 223 231
66. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
67. L.M. Sayre, M.A. Smith, and G. Perry Chemistry and biochemistry of oxidative stress in neurodegenerative disease Curr. Med. Chem. 8 2001 721 738
68. H. Reichmann, and P. Riederer Mitochondrial disturbances in neurodegeneration D.B. Calne Neurodegenerative Diseases 1994 Saunders Philadelphia 195 204
69. M. Beal Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases 1995 R.G. Landes Austin (TX)
70. M.P. Mattson Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease Int. Rev. Neurobiol. 53 2002 387 409
71. W.A. Jefferies, M.R. Food, R. Gabathuler, S. Rothenberger, T. Yamada, O. Yasuhara, and P.L. McGeer Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin Brain Res. 712 1996 122 126
72. B. Leveugle, G. Spik, D.P. Perl, C. Bouras, H.M. Fillit, and P.R. Hof The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis Brain Res. 650 1994 20 31
73. T. Kawamata, I. Tooyama, T. Yamada, D.G. Walker, and P.L. McGeer Lactotransferrin immunocytochemistry in Alzheimer and normal human brain Am. J. Pathol. 142 1993 1574 1585
74. M.A. Smith, R.K. Kutty, P.L. Richey, S.D. Yan, D. Stern, G.J. Chader, B. Wiggert, R.B. Petersen, and G. Perry Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease Am. J. Pathol. 145 1994 42 47
75. D.R. Premkumar, M.A. Smith, P.L. Richey, R.B. Petersen, R. Castellani, R.K. Kutty, B. Wiggert, G. Perry, and R.N. Kalaria Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease J. Neurochem. 65 1995 1399 1402
76. T. Kimpara, A. Takeda, T. Yamaguchi, H. Arai, N. Okita, S. Takase, H. Sasaki, and Y. Itoyama Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease Neurobiol. Aging 21 2000 551 554
77. J.E. Hamos, B. Oblas, D. Pulaski-Salo, W.J. Welch, D.G. Bole, and D.A. Drachman Expression of heat shock proteins in Alzheimer's disease Neurology 41 1991 345 350
78. J. Lowe, R.J. Mayer, and M. Landon Ubiquitin in neurodegenerative diseases Brain Pathol. 3 1993 55 65
79. J. Lowe, H. McDermott, I. Pike, I. Spendlove, M. Landon, and R.J. Mayer Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease J. Pathol. 166 1992 61 68
80. N. Perez, J. Sugar, S. Charya, G. Johnson, C. Merril, L. Bierer, D. Perl, V. Haroutunian, and W. Wallace Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease Brain Res. Mol. Brain Res. 11 1991 249 254
81. K. Renkawek, G.J. Bosman, and W.W. de Jong Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia Acta Neuropathol. (Berl.) 87 1994 511 519
82. D.A. Butterfield Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain Free Radic. Res. 36 2002 1307 1313
83. P.L. McGeer, and E.G. McGeer The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res. Brain Res. Rev. 21 1995 195 218
84. J.R. Connor Metals and oxidative damage in neurological disorders 1997 Plenum New York
85. M. Aschner Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels Neurotoxicology 21 2000 1101 1107
86. A. Ciechanover, and P. Brundin The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron 40 2003 427 446
87. E. Liebson, and M. Albert Cognitive changes in dementia of the Alzheimer type D.B. Calne Neurodegenerative diseases 1994 Saunders Philadelphia 615 629
88. R.L. Doty Olfactory dysfunction in neurodegenerative disorders T.V. Getchell R.L. Doty L.M. Bartoshuk J.B. Snow Jr. Smell and taste in health and disease 1991 Raven New York 735 751
89. R.M. Sapolsky Is this relevant to the human? R.M. Sapolsky Stress, the aging brain, and the mechanisms of neuron death 1992 MIT Press Cambridge (MA) 305 339
90. D. Parkes, J. Kasckow, and W. Vale Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures Brain Res. 646 1994 315 318
91. G.S. Marks, J.F. Brien, K. Nakatsu, and B.E. McLaughlin Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12 1991 185 188
92. C.F. Stevens, and Y. Wang Reversal of long-term potentiation by inhibitors of haem oxygenase Nature 364 1993 147 149
93. M. Zhuo, S.A. Small, E.R. Kandel, and R.D. Hawkins Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus Science 260 1993 1946 1950
94. A. Takeda, M.A. Smith, J. Avila, A. Nunomura, S.L. Siedlak, X. Zhu, G. Perry, and L.M. Sayre In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification J. Neurochem. 75 2000 1234 1241
95. H.M. Schipper, H. Chertkow, K. Mehindate, D. Frankel, C. Melmed, and H. Bergman Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD Neurology 54 2000 1297 1304
96. K. Ishizuka, T. Kimura, J. Yoshitake, T. Akaike, M. Shono, J. Takamatsu, S. Katsuragi, T. Kitamura, and T. Miyakawa Possible assessment for antioxidant capacity in Alzheimer's disease by measuring lymphocyte heme oxygenase-1 expression with real-time RT-PCR Ann. N. Y. Acad. Sci. 977 2002 173 178
97. H.M. Schipper, Y. Mawal, H. Chertkow, and H. Bergman Blood HO-1 mRNA in AD and MCI Neurology 57 2001 2142 2143
98. T. Kimpara, A. Takeda, K. Watanabe, Y. Itoyama, S. Ikawa, M. Watanabe, H. Arai, H. Sasaki, S. Higuchi, N. Okita, S. Takase, H. Saito, K. Takahashi, and S. Shibahara Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease Hum. Genet. 100 1997 145 147
99. S. Kravitz, Y. Mawal, D. Sahlas, A. Liberman, H. Chertkow, H. Bergman, and H. Schipper Heme oxygenase-1 suppressor activity in Alzheimer plasma Ann. Neurol. 52 Suppl. 1 2002 S31
100. D. Berlin, Y. Mawal, A. Liberman, and H. Schipper Partial characterization of a heme oxygenase-1 suppressor in Alzheimer plasma Ann. Neurol. 52 Suppl. 1 2002 S30
101. M. Takahashi, S. Dore, C.D. Ferris, T. Tomita, A. Sawa, H. Wolosker, D.R. Borchelt, T. Iwatsubo, S.H. Kim, G. Thinakaran, S.S. Sisodia, and S.H. Snyder Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease Neuron 28 2000 461 473
102. K. Jellinger, W. Paulus, I. Grundke-Iqbal, P. Riederer, and M.B. Youdim Brain iron and ferritin in Parkinson's and Alzheimer's diseases J. Neural Transm. Parkinson Dis. Dementia Sect. 2 1990 327 340
103. P. Jenner, and C.W. Olanow Understanding cell death in Parkinson's disease Ann. Neurol. 44 3 Suppl. 1 1998 S72 S84
104. C.M. Morris, and J.A. Edwardson Iron histochemistry of the substantia nigra in Parkinson's disease Neurodegeneration 3 1994 277 282
105. P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jellinger, and M.B. Youdim Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J. Neurochem. 52 1989 515 520
106. H.M. Schipper, Y. Kotake, and E.G. Janzen Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study J. Neurosci. 11 1991 2170 2176
107. B.A. Faucheux, N. Nillesse, P. Damier, G. Spik, A. Mouatt-Prigent, A. Pierce, B. Leveugle, N. Kubis, J.J. Hauw, and Y. Agid Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease Proc. Natl. Acad. Sci. USA 92 1995 9603 9607
108. B. Leveugle, B.A. Faucheux, C. Bouras, N. Nillesse, G. Spik, E.C. Hirsch, Y. Agid, and P.R. Hof Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases Acta Neuropathol. (Berl.) 91 1996 566 572
109. A.H. Schapira Causes of neuronal death in Parkinson's disease Adv. Neurol. 86 2001 155 162
110. M.F. Beal Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann. N. Y. Acad. Sci. 991 2003 120 131
111. R. Castellani, M.A. Smith, P.L. Richey, and G. Perry Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease Brain Res. 737 1996 195 200
112. T.J. Montine, D.B. Farris, and D.G. Graham Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation J. Neuropathol. Exp. Neurol. 54 1995 311 319
113. S. Krishnan, E.Y. Chi, S.J. Wood, B.S. Kendrick, C. Li, W. Garzon-Rodriguez, J. Wypych, T.W. Randolph, L.O. Narhi, A.L. Biere, M. Citron, and J.F. Carpenter Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis Biochemistry 42 2003 829 837
114. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S26 S36 discussion S8
115. A. Fernandez-Gonzalez, I. Perez-Otano, and J.I. Morgan MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes Eur. J. Neurosci. 12 2000 1573 1583
116. + Neuroreport 15 2004 1039 1044
117. H. Jiang, Z.M. Qian, and J.X. Xie [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice] Sheng Li Xue Bao 55 2003 571 576
118. H. Mochizuki, H. Imai, K. Endo, K. Yokomizo, Y. Murata, N. Hattori, and Y. Mizuno Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys Neurosci. Lett. 168 1994 251 253
119. J.A. Temlett, J.P. Landsberg, F. Watt, and G.W. Grime Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis J. Neurochem. 62 1994 134 146
120. J.D. Adams Jr., P.W. Kalivas, and C.A. Miller The acute histopathology of MPTP in the mouse CNS Brain Res. Bull. 23 1989 1 17
121. K. Mizukawa, Y.H. Sora, and N. Ogawa Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP)-treated mice Res. Commun. Chem. Pathol. Pharmacol. 67 1990 307 320
122. J. Lan, and D.H. Jiang Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice J. Neural Transm. 104 1997 469 481
123. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. Di Monte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
124. D.A. Di Monte, H.M. Schipper, S. Hetts, and J.W. Langston Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures Glia 15 1995 203 206
125. D. Frankel, and H.M. Schipper Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury Exp. Neurol. 160 1999 376 385
126. S.M. Levine, and A. Chakrabarty The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis Ann. N. Y. Acad. Sci. 1012 2004 252 266
127. R. Businaro, C. Fabrizi, B. Caronti, C. Calderaro, L. Fumagalli, and G.M. Lauro Myelin basic protein induces heme oxygenase-1 in human astroglial cells Glia 37 2002 83 88
128. F. Lu, M. Selak, J. O'Connor, S. Croul, C. Lorenzana, C. Butunoi, and B. Kalman Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis J. Neurol. Sci. 177 2000 95 103
129. A. Chakrabarty, M.R. Emerson, and S.M. Levine Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis Multiple Sclerosis 9 2003 372 381
130. Y. Liu, B. Zhu, L. Luo, P. Li, D.W. Paty, and M.S. Cynader Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis Neuroreport 12 2001 1841 1845
131. H.M. Bramlett, and W.D. Dietrich Pathophysiology of cerebral ischemia and brain trauma: similarities and differences J. Cereb. Blood Flow Metab. 24 2004 133 150
132. R. Beschorner, D. Adjodah, J.M. Schwab, M. Mittelbronn, I. Pedal, R. Mattern, H.J. Schluesener, and R. Meyermann Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans Acta Neuropathol. (Berl.) 100 2000 377 384
133. Y. Orihara, R. Tsuda, K. Ikematsu, I. Nakasono, and M. Ogata Immunohistochemical study on the induction of heme oxygenase-1 by traumatic brain injury Leg. Med. (Tokyo) 5 2003 S278 S279 (Suppl.)
134. R. Castellani, M.A. Smith, P.L. Richey, R. Kalaria, P. Gambetti, and G. Perry Evidence for oxidative stress in Pick disease and corticobasal degeneration Brain Res. 696 1995 268 271
135. L. Chang, M. Cornford, B.L. Miller, H. Itabashi, and I. Mena Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease Dementia 6 1995 1 8
136. M.B. Delisle, E. Uro-Coste, J.R. Murrell, O. Rascol, and B. Ghetti [Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein.] Bull. Acad. Natl. Med. 184 2000 799 809 discussion-811
137. H.J. Schluesener, P.G. Kremsner, and R. Meyermann Heme oxygenase-1 in lesions of human cerebral malaria Acta Neuropathol. (Berl.) 101 2001 65 68
138. M.H. Deininger, R. Meyermann, K. Trautmann, F. Duffner, E.H. Grote, J. Wickboldt, and H.J. Schluesener Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression Brain Res. 882 2000 1 8
139. E. Hara, K. Takahashi, T. Tominaga, T. Kumabe, T. Kayama, H. Suzuki, H. Fujita, T. Yoshimoto, K. Shirato, and S. Shibahara Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors Biochem. Biophys. Res. Commun. 224 1996 153 158
140. L. Policastro, B. Molinari, F. Larcher, P. Blanco, O.L. Podhajcer, C.S. Costa, P. Rojas, and H. Duran Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide Mol. Carcinog. 39 2004 103 113
141. W. Durante Heme oxygenase-1 in growth control and its clinical application to vascular disease J. Cell. Physiol. 195 2003 373 382
142. W. Droge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95